Pelizaeus-Merzbacher–like disease is an autosomal recessive disorder characterized by neonatal nystagmus, ataxia, progressive spasticity, and development delay and is rarely caused by GJC2 mutations. We report 7 patients from a large consanguineous family who had variable severity of Pelizaeus-Merzbacher–like disease. The 3 youngest of branch A were bedridden by their first year because of permanent scissoring of their legs and had severe frontal lobe epilepsy. The single patient from branch B was the least affected, being able to walk until 12 years of age and had no epilepsy. Brain magnetic resonance imaging (MRI) showed hypomyelination. The patients had a novel canonical splicing GJC2 c.-20+1G>C mutation with a predicted loss of the coding connexin 47 protein. The exceptionally large number of patients in this unique family enabled to describe the intrafamilial variability of Pelizaeus-Merzbacher–like disease. The predicted functional loss of connexin 47 might be associated with a severe form of Pelizaeus-Merzbacher–like disease.
HobsonGMGarbernJY.Pelizaeus-Merzbacher disease, Pelizaeus-Merzbacher-like disease 1, and related hypomyelinating disorders. Semin Neurol. 2012;32:62–67. Review.
2.
UhlenbergBSchuelkeMRüschendorfF. Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet. 2004;75:251–260.
3.
BugianiMAl ShahwanSLamanteaE. GJA12 mutations in children with recessive hypomyelinating leukoencephalopathy. Neurology2006;67:273–279.
4.
SalviatiLTrevissonEBaldoinMC. A novel deletion in the GJA12 gene causes Pelizaeus-Merzbacher-like disease. Neurogenetics2007;8:57–60.
5.
WolfNICundallMRutlandP. Frameshift mutation in GJA12 leading to nystagmus, spastic ataxia and CNS dys-/demyelination. Neurogenetics. 2007;8:39–44.
6.
HennekeMCombesPDiekmannS. GJA12 mutations are a rare cause of Pelizaeus-Merzbacher-like disease. Neurology2008;70:748–754.
7.
WangJWangHWangYChenTWuXJiangY. Two novel gap junction protein alpha 12 gene mutations in two Chinese patients with Pelizaeus-Merzbacher-like disease. Brain Dev. 2010;32:236–243.
8.
OsakaHHamanoueHYamamotoR. Disrupted SOX10 regulation of GJC2 transcription causes Pelizaeus–Merzbacher-like disease. Ann Neurol. 2010;68:250–254.
9.
MeyerEKurianMAMorganNV. Promoter mutation is a common variant in GJC2-associated Pelizaeus-Merzbacher-like disease. Mol Genet Metab. 2011;104:637–643.
10.
CombesPKammounNMonnierA. Relevance of GJC2 promoter mutation in Pelizaeus-Merzbacher-like disease. Ann Neurol. 2012;71:146–148.
11.
BilirBYapiciZYalcinkayaC. High frequency of GJA12/GJC2 mutations in Turkish patients with Pelizaeus-Merzbacher disease. Clin Genet. 2012. doi: 10.1111/j.1399-0004.2012.01846.x.
12.
OdermattBWellershausKWallraffA. Connexin 47 (Cx47)-deficient mice with enhanced green fluorescent protein reporter gene reveal predominant oligodendrocytic expression of Cx47 and display vacuolized myelin in the CNS. J Neurosci. 2003;23:4549–4559.
NagyJIIonescuAVLynnBDRashJE. Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice. Glia. 2003;44:205–218.
WasseffSKSchererSS. Cx32 and Cx47 mediate oligodendrocyte: astrocyte and oligodendrocyte: oligodendrocyte gap junction coupling. Neurobiol Dis. 2011;42:506–513.
17.
MaglioneMTressOHaasB. Oligodendrocytes in mouse corpus callosum are coupled via gap junction channels formed by connexin47 and connexin32. Glia. 2010;58:1104–1117.
18.
Al-YahyaeeSAl-GazaliLIDe JongheP. A novel locus for hereditary spastic paraplegia with thin corpus callosum and epilepsy. Neurology. 2006;66:1230–1234.
19.
RufNUhlenbergB. Analysis of human alternative first exons and copy number variation of the GJA12 gene in patients with Pelizaeus-Merzbacher-like disease. Am J Med Genet B Neuropsychiatr Genet. 2009;150B:226–232.
20.
HoudayerCCaux-MoncoutierVKriegerS. Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants. Hum Mutat. 2012;33:1228–1238.
21.
BrunakSEngelbrechtJKnudsenS. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol. 1991;220:49–65.
22.
LinWPopkoB.Endoplasmic reticulum stress in disorders of myelinating cells. Nat Neurosci. 2009;12:379–385. Review.
23.
Orthmann-MurphyJLSalsanoEAbramsCK. Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain. 2009;132(pt 2):426–438.
24.
TressOMaglioneMZlomuzicaA. Pathologic and phenotypic alterations in a mouse expressing a connexin47 missense mutation that causes Pelizaeus-Merzbacher-like disease in humans. PLoS Genet. 2011;7:e1002146.
25.
DiekmannSHennekeMBurckhardtBCGärtnerJ. Pelizaeus-Merzbacher-like disease is caused not only by a loss of connexin47 function but also by a hemichannel dysfunction. Eur J Hum Genet. 2010;18:985–992.
26.
LiXPenesMOdermattBWilleckeKNagyJI. Ablation of Cx47 in transgenic mice leads to the loss of MUPP1, ZONAB and multiple connexins at oligodendrocyte-astrocyte gap junctions. Eur J Neurosci. 2008;28:1503–1517.
27.
BaldaMSMatterK. The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J. 2000;19:2024–2033.
28.
KimJYSunQOglesbeeMYoonSO. The role of ErbB2 signaling in the onset of terminal differentiation of oligodendrocytes in vivo. J Neurosci. 2003;23:5561–5571.
